Patient Reported Outcomes

• Conceptual and endpoint models
• Discrete choice experiments
• ePRO SERVICES
• Market Research
• PRO evidence dossiers
• PRO instrument development
• PRO Statistical Analysis
• Strategic PRO advice
• Systematic and focussed literature reviews
• Training
• Translation and Linguistic Validation of PRO measures
• Utility and Patient preference studies

Patient Reported Outcomes

Patient Reported Outcomes (PRO) research is at the core of capability at Oxford Outcomes, and has been since the company's formation in 1997. We provide strategic PRO advice and research to support:

• Early stage exploration of product, health impact and value.
• Health technology appraisal to support regulatory/reimbursement submissions.
• Exploration and substantiation of labeling claims.
• Marketing and market research.

 

We deliver highly-credible science that supports regulatory, reimbursement, and marketing requirements for national and global markets. Our focus on scientific communication is also designed to ensure impact and resonance with the healthcare community.

PRO practice leaders: Andrew Lloyd, Diane Wild and Kathy Beusterien, are supported by a strong team of senior scientists and consultants based in our Oxford and Bethesda offices. Members of our team make key contributions to professional debate as consultees to FDA policy development, involvement with the ISPOR leadership group, DIA SIACs and the EUROQOL Group. Find out more about our team and see some of their recent publications.

Oxford Outcomes’ PRO team has well-developed networks of international opinion leaders, regulatory experts, investigators, and consultants. We also have collaborative relationships with a number of key researchers at: University of Oxford, University of Sheffield, University of Washington and University of York. One of our strengths is our ability to integrate this diverse range of scientific, commercial, and in-country expertise into our resource base.